Skinhealth (SKIN) Market Update

Trading performance Skinhealth shares ended the 24‑hour trading period at 11:11 PM Central Europe on Tuesday, 20 October 2026, down 0.09 %. The stock is currently trading at USD 11.16 on major exchanges.

Supply and valuation Outstanding shares total 6.5 million. The market capitalization is USD 68.7 million. In the last 24 hours, approximately USD 650.9 k of Skinhealth shares were traded.

Recent trend Since the end of the previous month, the share price has increased by 1,462.96 %. The 200‑day simple moving average is USD 1.20. The highest price in the last 52 weeks was USD 12.89, reached on 15 October 2026. The 52‑week low was USD 0.50, reached on 9 October 2026.

  • Usio (USIO) – up 1.42 %, now USD 2.85. Market cap USD 80.4 million. A current report filed on 19 October 2026 includes an investor presentation for the LD Micro Main Event (20 October) and the Planet MicroCap Toronto Conference (28 October). The report contains forward‑looking statements, financial statements, and confirms the company is not classified as an emerging growth company. No material events or leadership changes were disclosed.
  • Citius Oncology (CTOR) – down 7.55 %, now USD 0.67. Market cap USD 81.2 million.
  • Innovate (VATE) – down 0.83 %, now USD 5.92. Market cap USD 81.9 million.
  • Biotechnology (PDSB) – down 18.85 %, now USD 0.96. Market cap USD 81.9 million.
  • Empery Digital (EMPD) – down 6.51 %, now USD 2.87. Market cap USD 82.1 million. A report filed on 19 October 2026 announced the outcomes of the 14 October annual shareholders’ meeting: nine directors elected for a one‑year term, a rejected proposal to adopt the 2025 Equity Incentive Plan, and the appointment of MaloneBailey, LLP as independent auditor for 2026. ATG Capital Opportunities Fund subsequently launched a Section 225 action to replace a board member. The filing confirms Empery Digital’s status as an emerging growth company and contains no market‑moving information beyond board and audit matters.

Company Overview

Skinhealth is a consumer‑staples company headquartered in Long Beach, United States, listed on Nasdaq. The company positions itself as a bridge between medical and consumer retail, aiming to democratize and personalize skin‑care solutions for estheticians, consumers, and partners worldwide. Investor information is available at investors.beautyhealth.com.